| |
|
| Year : 1984 | Volume
: 50
| Issue : 3 | Page : 131--133 |
Evaluation of Rifampicin For Cutaneous Leishmanias
Ramji Gupta, JS Pasricha
,
Correspondence Address:
Ramji Gupta
Eight patients having cutaneous leishmaniasis were giving 150- 1200 mg rifampi4#n a day orally depending upon the age and body weight of the patient. Treatment was stopped after 2 months if there was no improvement; otherwise it was continued till complete regression of the lesion (s). In 2 patients the lesions regressed completely in 2 month and 6 months respectively, 3 patients improved partially, while the remaining 3&&k4.00H showed no improvement at all.
[PDF Not available]*
|
